Supernus Pharmaceuticals, Inc. (SUPN)

47.16 +0.65 (+1.40%) USD  |  NASDAQ  |  Dec 12, 16:00
47.18 +0.02 (+0.04%) After-Hours: 20:00
More

Supernus Pharmaceuticals Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Biogen, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
CorMedix, Inc. Upgrade
Assembly Biosciences, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade